Ultravax S3 Ointment 1's

Ultravax S3 Ointment 1's belongs to the class of ‘dermatological agents’ primarily used in the treatment of skin diseases such as eczema and psoriasis. Eczema is a condition in which skin becomes red, itchy, and inflamed due to external agents such as soaps, dyes, or other irritants. Psoriasis is an autoimmune (immune system attacks healthy cells) skin disorder in which the skin becomes scaly, swelled up, and itchy.

Ultravax S3 Ointment 1's is a combination of two medicines: Halobetasol and Salicylic acid. Halobetasol belongs to the class of corticosteroids and it has anti-inflammatory, immunosuppressive, and antiproliferative (inhibit cell growth) properties. It blocks the production of prostaglandins (chemical messengers) that cause inflammatory symptoms such as red, swollen, and itchy rashes. Salicylic acid enhances the activity of halobetasol. It is a keratolytic medicine that breaks down the clumps of keratin (protein present on the skin), removes dead skin cells, and softens the skin. It also acts as an anti-inflammatory and topical antibacterial agent.

You should use this medicine as prescribed by your doctor. Ultravax S3 Ointment 1's may cause side effects such as itching, dryness, irritation, and burning sensation at the application site, stretch marks, headache, and cold symptoms such as stuffy nose or sneezing. These side effects usually do not require medical attention and gradually resolve over time. However, if you notice any other symptoms or the side effects persist longer, please consult your doctor.

Do not use Ultravax S3 Ointment 1's if you are allergic to Halobetasol, Salicylic acid, or any other ingredients present in it. Before taking Ultravax S3 Ointment 1's, inform your doctor if you have any type of skin infection, a skin reaction to any steroid medicine, an adrenal gland disorder, liver disease, or planning to have surgery. Ultravax S3 Ointment 1's should not be used in children under 12 years of age. Inform your doctor if you are pregnant or breastfeeding.

Ultravax S3 Ointment 1's is a combination of two medicines: Halobetasol and Salicylic acid. Halobetasol belongs to the class of corticosteroids and it has anti-inflammatory, immunosuppressive, and antiproliferative (inhibit cell growth) properties. It blocks the production of prostaglandins (chemical messengers that cause the skin to become red, swollen, and itchy). Salicylic acid enhances the absorption of Halobetasol. It is a keratolytic medicine (softens, separates, and peels the horny layer of skin), which breaks down the clumps of keratin, removes dead skin cells, and softens the skin. It is also an anti-inflammatory and topical antibacterial agent.

Stop using Ultravax S3 Ointment 1's and inform your doctor immediately, if you notice any persistent skin irritation, worsening of the skin disease, high blood sugar (symptoms include increased thirst, increased urination, dry mouth), blurred vision, or other visual disturbances, or weight gain. If you are using Ultravax S3 Ointment 1's to treat plaque psoriasis, you should stop taking this medicine when your symptoms are improved. Do not use the medicine on the face, scalp, underarms, or groin area. Do not smoke or go near flames as there is a risk of serious burns with the salicylic acid present in Ultravax S3 Ointment 1's. Avoid using other topical medicines on the affected area while using Ultravax S3 Ointment 1's.